Management Team
A Future-Ready Leadership of Vision & Resolve
Granules Pharmaceuticals Inc. is led by a team of seasoned professionals of the pharmaceutical industry. Each leader brings in-depth expertise and a modern outlook to tackle the challenges of today’s dynamic business. Collectively, the Granules leadership chalks out strategies that helps in building organisational capability while delivering sustainable growth.
Mr. Cormac Long
Executive Vice President of Strategy & Business Development
Cormac has a Bachelor’s and PhD in Chemistry from the National University of Ireland, Galway. Prior to joining Granules Cormac held leadership roles in key strategic functions like corporate strategy, portfolio management, project management and business development at several leading pharmaceutical organizations through periods of growth and adversity.
Mr. Nivaran Kapur
PRESIDENT OF GRANULES CONSUMER HEALTH
Nivaran Kapur is the President of Granules Consumer Health. Nivaran is responsible for all commercial activities and strategic initiatives of OTC finished dosages in North America. He has been involved since the inception of the division and established Granules Consumer as a dependable supplier in the OTC space. Prior to Granules, Nivaran was the President of Aurohealth, an Aurobindo company, that sells OTC finished Dosages in North America.
Ms. Priyanka Chigurupati
EXECUTIVE DIRECTOR OF GRANULES PHARMACEUTICALS INC. & GRANULES USA
Ms. Priyanka Chigurupati is the Executive Director of Granules Pharmaceuticals, Inc. and responsible for the US Generics business and Investor Relations. Ms. Chigurupati has a Bachelor of Science degree in Business Management from Case Western Reserve University(US). Within Granules, she has had a variety of roles across several divisions in the US and in India within R&D, Commercial Operations and Investor Relations.
Mr. Vijay Ramanavarapu
PRESIDENT OF GRANULES PHARMACEUTICALS INC. & GRANULES USA
Vijay Ramanavarapu is the President of Granules USA and Granules Pharmaceuticals. Vijay is responsible for commercial activities involving bulk API and OTC finished dosages in North America as well as operational activities at GPI. Vijay has served in a variety of roles at Granules within its Indian and Chinese offices including heading supply chain and investor relations. Prior to Granules, Vijay was an investment banking analyst in California.
Mr. Jason Hanks
Chief Commercial Officer
Mr. Jason Hanks earned a Bachelor of Science Degree in Finance from California State University, Chico and a Masters of Business Administration from Golden Gate University. Over the past 25 years, Mr. Hanks has held leadership roles in Finance, Business Development, and Procurement at such healthcare companies as Bristol-Myers Squibb and the McKesson Corporation.
In his current role, Hanks heads Sales and Marketing for Granules Pharmaceuticals Inc. He launched Granules’ first pharmaceutical product in 2018 and continues to manage the expanding portfolio of generic drugs being developed and manufactured for the US Healthcare System.
Mr. Kamal Mandan
CHIEF FINANCIAL OFFICER
Mr. Kamal Mandan is a Chartered Accountant from India and a US Certified Public Accountant. Mr. Mandan has worked in Engineering, Chemical and Pharmaceutical Industry over the last 30 years at various roles with last 16 years in Pharmaceuticals.
Mr. Mandan joined Granules Pharmaceuticals Inc. in September 2018 as CFO, prior to which he worked with the Indian multinational Jubilant Group at different locations in India, Belgium and US and was involved in cross border M&A and bringing post-acquisition synergies with Indian parent.
Mr. Bret Svedberg
HEAD OF HUMAN RESOURCES, NORTH AMERICA
-
Mr. David Rekenthaler
CHIEF COMMERCIAL OFFICER , NORTH AMERICA
